Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Gilead To Use Insitro’s AI/Functional Genomics Tech For NASH Targets

Apr 17 2019

• By Joseph Haas

DealWatch_1200x675 — Insitro and Gilead ink NASH deal; updates from Catalent, Boehringer, PureTech, Fibrocell

Related Content

Failed Phase III For NeoCart May Still Fly With US FDA, Histogenics Argues

Sep 06 2018

Hansa Raises More Cash For Pipeline With Genovis Stake Sale

Apr 16 2019

Alnylam Replaces Sanofi Partnership With Second Regeneron Tie-Up For RNAi Drugs

Apr 08 2019

Gilead Hit With Another NASH Setback As Selonsertib Fails In First Phase III

Feb 11 2019

Struggling Fibrocell To Consider All Strategic Directions Going Forward

Apr 18 2018

Ocugen Heads Toward Phase III In Dry Eye With Potential Benefits Over Older Drugs

Mar 20 2018

Immunic of Germany Set For Nasdaq After Merger With Failed Vital Therapies

Jan 08 2019

Gilead Increasingly Seems Focused On Combo Therapy In NASH

Apr 12 2019

As Expected: Shareholders Back Bristol's $74bn Celgene Buy

Apr 12 2019

Related Companies

Gilead Sciences, Inc.

Novo Nordisk A/S

Catalent, Inc

Paragon Biosciences LLC

Boehringer Ingelheim GmbH

PureTech Health plc

Fibrocell Science, Inc.

Castle Creek Biosciences, Inc.

Immunic Inc.

Vital Therapies, Inc.

Histogenics Corporation

Ocugen Inc.

Massachusetts Eye & Ear Infirmary

Hansa Biopharma AB

Genovis AB

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals Inc.

Sanofi

Additional Topics

Deals Business Strategies Commercial M & A BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.